Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Celdara Medical in January, 2021 for $299,916.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI157527-01 | Phase I | 299,916 | January 1, 2021 | |||||||
A SBIR Phase II contract was awarded to Celdara Medical in March, 2020 for $962,825.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI136273-03 | Phase II | 962,825 | March 25, 2020 | |||||||
A SBIR Phase II contract was awarded to Celdara Medical in September, 2018 for $1,488,101.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AR072170-02 | Phase II | 1,488,101 | September 14, 2018 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in February, 2018 for $595,060.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI136273-01A1 | Phase I | 595,060 | February 16, 2018 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in September, 2022 for $267,818.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK135154-01 | Phase I | 267,818 | September 22, 2022 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in May, 2019 for $224,170.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK117714-01A1 | Phase I | 224,170 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in January, 2019 for $299,998.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI142911-01 | Phase I | 299,998 | January 1, 2019 | |||||||
A STTR Phase I contract was awarded to Celdara Medical in April, 2020 for $258,360.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI147902-01A1 | Phase I | 258,360 | April 17, 2020 | |||||||
A SBIR Phase II contract was awarded to Celdara Medical in September, 2019 for $749,904.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AR073067-02 | Phase II | 749,904 | September 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in September, 2019 for $298,691.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI148004-01 | Phase I | 298,691 | September 5, 2019 | |||||||
A SBIR Phase II contract was awarded to Celdara Medical in August, 2020 for $998,624.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DK117714-02 | Phase II | 998,624 | August 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in September, 2020 for $299,152.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK125161-01A1 | Phase I | 299,152 | September 11, 2020 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in August, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA224750-01A1 | Phase I | 300,000 | August 9, 2018 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in April, 2022 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI157074-01A1 | Phase I | 300,000 | April 25, 2022 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in September, 2021 for $274,085.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA265424-01 | Phase I | 274,085 | September 8, 2021 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in August, 2022 for $368,052.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA271880-01A1 | Phase I | 368,052 | August 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in August, 2022 for $300,590.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL162238-01A1 | Phase I | 300,590 | August 10, 2022 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical for $598,006.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 272201800035C-0-0-0 | Phase I | 598,006 | ||||||||
A SBIR Phase I contract was awarded to Celdara Medical for $599,234.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93019C00038 | Phase I | 599,234 | ||||||||
A SBIR Phase II contract was awarded to Celdara Medical in September, 2022 for $712,718.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA265424-02 | Phase II | 712,718 | September 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical for $599,977.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93020C00041 | Phase I | 599,977 | ||||||||
A STTR Phase II contract was awarded to Celdara Medical in September, 2019 for $1,716,246.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 4UT2GM130176-02 | Phase II | 1,716,246 | September 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Celdara Medical in May, 2017 for $1,999,085.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA217365-01 | Phase II | 1,999,085 | May 12, 2017 | |||||||
A SBIR Phase II contract was awarded to Celdara Medical in September, 2014 for $1,494,019.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AR061920-02A1 | Phase II | 1,494,019 | September 23, 2014 | |||||||
A SBIR Phase I contract was awarded to Celdara Medical in May, 2015 for $299,052.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA192540-01 | Phase I | 299,052 | May 1, 2015 |